Company intelligence / Profile preview

Paragon Vision Sciences

Gilbert, Arizona, United States

Ownership: Private
Employees: ~102
Development stage: Other

Overview

Paragon CRT lenses are FDA-approved for overnight wear and have been prescribed to over 1.5 million patients in 50+ countries for myopia management; over 90% of patients can achieve 20/40 vision or better

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

CooperVision (parent, integration and distribution)

Beyond the preview

Go deeper on Paragon Vision Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paragon Vision Sciences.

Explore the full profile